Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer
100%
Gene Expression Data
100%
Prostate Cancer Biomarker
100%
Prostate Tissue
40%
High-level Expression
20%
Treatment Decisions
20%
Literature Analysis
20%
Normal Prostate
20%
Multivariate Model
20%
Prostate-specific Antigen
20%
Tumor Tissue
20%
Publicly Available
20%
Early Detection
20%
Microarray Analysis
20%
Prognostic Marker
20%
Diagnostic Marker
20%
Genomic Data
20%
Discrimination Power
20%
Relapsed Disease
20%
Subset Sampling
20%
Filamin A
20%
Prostate Cancer Risk
20%
Early Surgery
20%
Multigene
20%
KLK3
20%
Early Cancer Detection
20%
Preventive Screening
20%
Tissue Specificity
20%
Prostate Cancer Markers
20%
Prognostic Potential
20%
Racemase
20%
Diagnostic Test
20%
Prognostic Test
20%
Diagnostic Potential
20%
Cancer Prognosis
20%
Indolent Prostate Cancer
20%
Response Prediction
20%
Gleason Scoring
20%
Response Detection
20%
Prostate Cancer Antigen 3 (PCA3)
20%
Neoplasms
20%
Claudin-3
20%
Residual Disease
20%
Integrated Genomics
20%
Keratin 5
20%
Early Prostate Cancer
20%
C(V)
20%
Risk of Progression
20%
Additional Markers
20%
INIS
data
100%
roads
100%
genes
100%
validation
100%
cancer
100%
biological markers
100%
travel
100%
prostate
100%
tissues
38%
indicators
23%
detection
23%
screening
15%
mortality
15%
levels
7%
risks
7%
information
7%
power
7%
tumors
7%
diseases
7%
sampling
7%
prediction
7%
testing
7%
surgery
7%
antigens
7%
specificity
7%
multivariate analysis
7%
lethals
7%
keratin
7%
neoplasms
7%
Biochemistry, Genetics and Molecular Biology
Gene Expression Data
100%
Genomics
100%
Cohort Study
50%
PCA3
50%
Tissue Specificity
50%
Prostate-Specific Antigen
50%
Tumor Marker
50%
Keratin 5
50%
Filamin
50%
Claudin
50%
Medicine and Dentistry
Gene Expression
100%
Prostate Cancer
100%
Cancer Biomarkers
100%
Neoplasm
22%
Prostate Tissue
22%
Biological Marker
11%
Prostate Specific Antigen
11%
Microarray Analysis
11%
Cohort Analysis
11%
Recurrent Disease
11%
Racemase
11%
Filamin
11%
Tumor Marker
11%
Claudin 3
11%
Tissue Specificity
11%
PCA3
11%
Early Cancer Diagnosis
11%
Keratin 5
11%
Cancer Prognosis
11%
Minimal Residual Disease
11%
Base
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Biological Marker
100%
Neoplasm
20%
Cohort Study
10%
Cytokeratin 5
10%
Prostate Specific Antigen
10%
Recurrent Disease
10%
Filamin
10%
Claudin 3
10%
Racemase
10%
Cancer Prognosis
10%
Base
10%
Tumor Marker
10%
Minimal Residual Disease
10%